Alpha-Fetoprotein

The C-reactive protein and alpha-fetoprotein in immunotherapy score identified patients with favorable hepatocellular carcinoma disease control and survival, according to a study presented at the International Liver Congress.

BOSTON — In this exclusive video from The Liver Meeting 2019, Naga P. Chalasani, MD, from the Indiana University School of Medicine, discusses the accuracy of combined methylated DNA and protein markers for early-stage detection of hepatocellular carcinoma.

As liver cancer rates continue to increase globally, researchers have focused on novel treatment options including combination therapies and second-line options for patients with insufficient response to initial therapy.